All Relations between Schizophrenia and Clozapine

Publication Sentence Publish Date Extraction Date Species
P M Llorca, C Lancon, J Farisse, J C Scott. Clozapine and negative symptoms. An open study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 3. 2000-09-25. PMID:10836486. the authors studied the efficacy of clozapine in an open study in a population of 51 patients, who met the dsm iv criteria for schizophrenia. 2000-09-25 2023-08-12 Not clear
P M Llorca, C Lancon, J Farisse, J C Scott. Clozapine and negative symptoms. An open study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 3. 2000-09-25. PMID:10836486. ), we try to identify the specificity of the action of clozapine on the different symptomatic dimensions of schizophrenia. 2000-09-25 2023-08-12 Not clear
M Mark, R Magnezi, O Luxenburg, M Siebzehner, J Sheme. [Clozapine in the treatment of schizophrenia]. Harefuah. vol 137. issue 5-6. 2000-09-25. PMID:10959316. [clozapine in the treatment of schizophrenia]. 2000-09-25 2023-08-12 Not clear
M L Lu, H Y Lane, K P Chen, M W Jann, M H Su, W H Chan. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. The Journal of clinical psychiatry. vol 61. issue 8. 2000-09-14. PMID:10982203. concomitant fluvoxamine use can potentially reduce the dosage of clozapine needed in treatment-refractory patients with schizophrenia. 2000-09-14 2023-08-12 Not clear
S Frangou, M Lewi. Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. European psychiatry : the journal of the Association of European Psychiatrists. vol 15. issue 3. 2000-08-24. PMID:10881220. the aim of this paper was to examine the use of atypical antipsychotics in clinical care, by means of a survey of prescribing practices for clozapine, risperidone, olanzapine, sertindole and quetiapine for all patients treated for dsm-iv schizophrenia within a psychiatric service. 2000-08-24 2023-08-12 Not clear
S Frangou, M Lewi. Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. European psychiatry : the journal of the Association of European Psychiatrists. vol 15. issue 3. 2000-08-24. PMID:10881220. the new atypical antipsychotics appear to be replacing older neuroleptics as the first-line treatment of schizophrenia while clozapine is mostly reserved for poor responders. 2000-08-24 2023-08-12 Not clear
Z A Sharif, A Raza, S S Ratakond. Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. The Journal of clinical psychiatry. vol 61. issue 7. 2000-08-21. PMID:10937608. comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. 2000-08-21 2023-08-12 Not clear
S Raskin, G Katz, Z Zislin, H Y Knobler, R Durs. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta psychiatrica Scandinavica. vol 101. issue 4. 2000-07-14. PMID:10782556. clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. 2000-07-14 2023-08-12 Not clear
S Raskin, G Katz, Z Zislin, H Y Knobler, R Durs. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta psychiatrica Scandinavica. vol 101. issue 4. 2000-07-14. PMID:10782556. clozapine and risperidone were the first two antipsychotic drugs of a new class of agents for the pharmacotherapy of schizophrenia. 2000-07-14 2023-08-12 Not clear
H E Shannon, K Rasmussen, F P Bymaster, J C Hart, S C Peters, M D Swedberg, L Jeppesen, M J Sheardown, P Sauerberg, A Fink-Jense. Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophrenia research. vol 42. issue 3. 2000-07-11. PMID:10785583. the present results thus demonstrate that xanomeline has a pharmacologic profile which is similar to that of the atypical antipsychotics clozapine and olanzapine, thus indicating that xanomeline has the potential to be a novel approach in the treatment of psychotic symptoms in patients with schizophrenia. 2000-07-11 2023-08-12 mouse
K Wahlbeck, M Cheine, M A Essal. Clozapine versus typical neuroleptic medication for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2000-07-06. PMID:10796289. clozapine versus typical neuroleptic medication for schizophrenia. 2000-07-06 2023-08-12 Not clear
A Tuunainen, K Wahlbeck, S M Gilbod. Newer atypical antipsychotic medication versus clozapine for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2000-07-06. PMID:10796559. newer atypical antipsychotic medication versus clozapine for schizophrenia. 2000-07-06 2023-08-12 Not clear
J Waserman, M Crioll. Subjective experiences of clozapine treatment by patients with chronic schizophrenia. Psychiatric services (Washington, D.C.). vol 51. issue 5. 2000-06-27. PMID:10783189. subjective experiences of clozapine treatment by patients with chronic schizophrenia. 2000-06-27 2023-08-12 Not clear
M Sajatovic, C R Bingham, D Garver, L F Ramirez, G Ripper, F Blow, L S Lehman. An assessment of clinical practice of clozapine therapy for veterans. Psychiatric services (Washington, D.C.). vol 51. issue 5. 2000-06-27. PMID:10783190. clozapine therapy for 2,996 patients with treatment-refractory schizophrenia was examined over a five-year period in the veterans affairs health care system. 2000-06-27 2023-08-12 Not clear
A E Evins, S M Fitzgerald, L Wine, R Rosselli, D C Gof. Placebo-controlled trial of glycine added to clozapine in schizophrenia. The American journal of psychiatry. vol 157. issue 5. 2000-05-17. PMID:10784481. placebo-controlled trial of glycine added to clozapine in schizophrenia. 2000-05-17 2023-08-12 Not clear
A E Evins, S M Fitzgerald, L Wine, R Rosselli, D C Gof. Placebo-controlled trial of glycine added to clozapine in schizophrenia. The American journal of psychiatry. vol 157. issue 5. 2000-05-17. PMID:10784481. the purpose of this study was to evaluate the effects of high-dose oral glycine on positive and negative symptoms and cognitive function when added to clozapine in adults with schizophrenia. 2000-05-17 2023-08-12 Not clear
J Munro, D O'Sullivan, C Andrews, A Arana, A Mortimer, R Kerwi. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. The British journal of psychiatry : the journal of mental science. vol 175. 2000-05-12. PMID:10789357. people prescribed clozapine for treatment-resistant schizophrenia have mandatory haematological monitoring through a case register for identifying reversible neutropenia. 2000-05-12 2023-08-12 Not clear
R Berecz, T Glaub, M Kellermann, A de la Rubia, A Llerena, I Degrel. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient. Pharmacopsychiatry. vol 33. issue 1. 2000-05-10. PMID:10721883. a 30-year-old male patient with paranoid schizophrenia was on clozapine therapy for more than five years. 2000-05-10 2023-08-12 Not clear
S A Chong, G J Remington, N Lee, R Mahendra. Contrasting clozapine prescribing patterns in the east and west? Annals of the Academy of Medicine, Singapore. vol 29. issue 1. 2000-05-04. PMID:10748970. in this survey, we compared the effect of clozapine, an atypical neuroleptic, on polypharmacy in two groups of patients with schizophrenia in two different settings. 2000-05-04 2023-08-12 Not clear
J P Pandarakala. Atypical neuroleptics. Hospital medicine (London, England : 1998). vol 61. issue 1. 2000-04-20. PMID:10735147. the discovery that clozapine alleviates both positive and negative symptoms of schizophrenia has resulted in the emergence of newer atypical neuroleptics. 2000-04-20 2023-08-12 Not clear